These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1043 related articles for article (PubMed ID: 21109934)
1. Overexpression of fibroblast growth factor receptor 4 in high-grade pancreatic intraepithelial neoplasia and pancreatic ductal adenocarcinoma. Motoda N; Matsuda Y; Onda M; Ishiwata T; Uchida E; Naito Z Int J Oncol; 2011 Jan; 38(1):133-43. PubMed ID: 21109934 [TBL] [Abstract][Full Text] [Related]
2. Loss of heterozygosity status of D9S105 marker is associated with downregulation of Krüppel-like factor 4 expression in pancreatic ductal adenocarcinoma and pancreatic intraepithelial lesions. Funel N; Morelli M; Giovannetti E; Del Chiaro M; Pollina LE; Mosca F; Boggi U; Cavazzana A; Campani D Pancreatology; 2011; 11(1):30-42. PubMed ID: 21412023 [TBL] [Abstract][Full Text] [Related]
3. The biological features of PanIN initiated from oncogenic Kras mutation in genetically engineered mouse models. Shen R; Wang Q; Cheng S; Liu T; Jiang H; Zhu J; Wu Y; Wang L Cancer Lett; 2013 Oct; 339(1):135-43. PubMed ID: 23887057 [TBL] [Abstract][Full Text] [Related]
4. Origin of pancreatic ductal adenocarcinoma from atypical flat lesions: a comparative study in transgenic mice and human tissues. Aichler M; Seiler C; Tost M; Siveke J; Mazur PK; Da Silva-Buttkus P; Bartsch DK; Langer P; Chiblak S; Dürr A; Höfler H; Klöppel G; Müller-Decker K; Brielmeier M; Esposito I J Pathol; 2012 Apr; 226(5):723-34. PubMed ID: 21984419 [TBL] [Abstract][Full Text] [Related]
5. Expression of urocortin in pancreatic ductal adenocarcinoma and pancreatic intraepithelial neoplasia. Cheng MF; Tsai WC; Hsia KT; Yang YS; Jin JS APMIS; 2014 Feb; 122(2):147-54. PubMed ID: 23755913 [TBL] [Abstract][Full Text] [Related]
6. In vitro modeling of human pancreatic duct epithelial cell transformation defines gene expression changes induced by K-ras oncogenic activation in pancreatic carcinogenesis. Qian J; Niu J; Li M; Chiao PJ; Tsao MS Cancer Res; 2005 Jun; 65(12):5045-53. PubMed ID: 15958547 [TBL] [Abstract][Full Text] [Related]
7. Serine protease inhibitor Kazal type 1 and epidermal growth factor receptor are expressed in pancreatic tubular adenocarcinoma, intraductal papillary mucinous neoplasm, and pancreatic intraepithelial neoplasia. Ozaki N; Ohmuraya M; Ida S; Hashimoto D; Ikuta Y; Chikamoto A; Hirota M; Baba H J Hepatobiliary Pancreat Sci; 2013 Aug; 20(6):620-7. PubMed ID: 23475261 [TBL] [Abstract][Full Text] [Related]
8. Early requirement of Rac1 in a mouse model of pancreatic cancer. Heid I; Lubeseder-Martellato C; Sipos B; Mazur PK; Lesina M; Schmid RM; Siveke JT Gastroenterology; 2011 Aug; 141(2):719-30, 730.e1-7. PubMed ID: 21684285 [TBL] [Abstract][Full Text] [Related]
9. Pancreatic intraepithelial neoplasia in heterotopic pancreas: evidence for the progression model of pancreatic ductal adenocarcinoma. Zhang L; Sanderson SO; Lloyd RV; Smyrk TC Am J Surg Pathol; 2007 Aug; 31(8):1191-5. PubMed ID: 17667542 [TBL] [Abstract][Full Text] [Related]
10. Effects of bone sialoprotein on pancreatic cancer cell growth, invasion and metastasis. Kayed H; Kleeff J; Keleg S; Felix K; Giese T; Berger MR; Büchler MW; Friess H Cancer Lett; 2007 Jan; 245(1-2):171-83. PubMed ID: 16488077 [TBL] [Abstract][Full Text] [Related]
11. MicroRNAs as diagnostic markers for pancreatic ductal adenocarcinoma and its precursor, pancreatic intraepithelial neoplasm. Xue Y; Abou Tayoun AN; Abo KM; Pipas JM; Gordon SR; Gardner TB; Barth RJ; Suriawinata AA; Tsongalis GJ Cancer Genet; 2013 Jun; 206(6):217-21. PubMed ID: 23933230 [TBL] [Abstract][Full Text] [Related]
12. BGLAP is expressed in pancreatic cancer cells and increases their growth and invasion. Kayed H; Bekasi S; Keleg S; Michalski CW; Giese T; Friess H; Kleeff J Mol Cancer; 2007 Dec; 6():83. PubMed ID: 18163903 [TBL] [Abstract][Full Text] [Related]
13. Differential cell cycle and proliferation marker expression in ductal pancreatic adenocarcinoma and pancreatic intraepithelial neoplasia (PanIN). Karamitopoulou E; Zlobec I; Tornillo L; Carafa V; Schaffner T; Brunner T; Borner M; Diamantis I; Zimmermann A; Terracciano L Pathology; 2010 Apr; 42(3):229-34. PubMed ID: 20350215 [TBL] [Abstract][Full Text] [Related]
14. Gamma-aminobutyric acid (GABA) stimulates pancreatic cancer growth through overexpressing GABAA receptor pi subunit. Takehara A; Hosokawa M; Eguchi H; Ohigashi H; Ishikawa O; Nakamura Y; Nakagawa H Cancer Res; 2007 Oct; 67(20):9704-12. PubMed ID: 17942900 [TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical validation of a novel epithelial and a novel stromal marker of pancreatic ductal adenocarcinoma identified by global expression microarrays: sea urchin fascin homolog and heat shock protein 47. Maitra A; Iacobuzio-Donahue C; Rahman A; Sohn TA; Argani P; Meyer R; Yeo CJ; Cameron JL; Goggins M; Kern SE; Ashfaq R; Hruban RH; Wilentz RE Am J Clin Pathol; 2002 Jul; 118(1):52-9. PubMed ID: 12109856 [TBL] [Abstract][Full Text] [Related]
16. Amplification and overexpression of HER-2/neu in invasive ductal carcinomas of the pancreas and pancreatic intraepithelial neoplasms and the relationship to the expression of p21(WAF1/CIP1). Hermanová M; Lukás Z; Nenutil R; Brázdil J; Kroupová I; Kren L; Pazourková M; Růzicka M; Díte P Neoplasma; 2004; 51(2):77-83. PubMed ID: 15190415 [TBL] [Abstract][Full Text] [Related]
17. Analysis of the pancreatic tumor progression by a quantitative proteomic approach and immunhistochemical validation. Sitek B; Sipos B; Alkatout I; Poschmann G; Stephan C; Schulenborg T; Marcus K; Lüttges J; Dittert DD; Baretton G; Schmiegel W; Hahn SA; Klöppel G; Meyer HE; Stühler K J Proteome Res; 2009 Apr; 8(4):1647-56. PubMed ID: 19714807 [TBL] [Abstract][Full Text] [Related]
18. Localization of the human hedgehog-interacting protein (Hip) in the normal and diseased pancreas. Kayed H; Kleeff J; Esposito I; Giese T; Keleg S; Giese N; Büchler MW; Friess H Mol Carcinog; 2005 Apr; 42(4):183-92. PubMed ID: 15754313 [TBL] [Abstract][Full Text] [Related]
19. Overexpression of cellular inhibitor of apoptosis protein 2 is an early event in the progression of pancreatic cancer. Esposito I; Kleeff J; Abiatari I; Shi X; Giese N; Bergmann F; Roth W; Friess H; Schirmacher P J Clin Pathol; 2007 Aug; 60(8):885-95. PubMed ID: 16775116 [TBL] [Abstract][Full Text] [Related]
20. Expression analysis of PMP22/Gas3 in premalignant and malignant pancreatic lesions. Li J; Kleeff J; Esposito I; Kayed H; Felix K; Giese T; Büchler MW; Friess H J Histochem Cytochem; 2005 Jul; 53(7):885-93. PubMed ID: 15995147 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]